APA (7th ed.) Citation

AC, W., M, M., BM, S., A, M., G, B., D, A., . . . DA, P. (2024). Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine. Haematologica, 109(6), 1766. https://doi.org/10.3324/haematol.2023.283790

Chicago Style (17th ed.) Citation

AC, Winters, et al. "Multi-gene Measurable Residual Disease Assessed by Digital Polymerase Chain Reaction Has Clinical and Biological Utility in Acute Myeloid Leukemia Patients Receiving Venetoclax/azacitidine." Haematologica 109, no. 6 (2024): 1766. https://doi.org/10.3324/haematol.2023.283790.

MLA (9th ed.) Citation

AC, Winters, et al. "Multi-gene Measurable Residual Disease Assessed by Digital Polymerase Chain Reaction Has Clinical and Biological Utility in Acute Myeloid Leukemia Patients Receiving Venetoclax/azacitidine." Haematologica, vol. 109, no. 6, 2024, p. 1766, https://doi.org/10.3324/haematol.2023.283790.